Two Philly-Area Groups Vie For New Federal Regional Tech Hub Designation

August 18, 2023

Under the CHIPS and Science Act, the U.S. Commerce Department will award 20 or more winning regions $50 million to $75 million to create globally competitive industry clusters.   Two Philly-area groups focused on biotechnology and precision medicine want to win a new federal designation as regional tech and innovation hubs under a U.S. Department […]

Read More

Four Leaders To Be Honored By The Science Center At 2023 Nucleus Awards

August 15, 2023

Celebrating 60 years of scientific innovation, the Science Center will honor four individuals who have demonstrated leadership in fostering a more innovative, collaborative, and equitable future during its annual Nucleus Awards, presented by CSL. The Nucleus Awards, taking place on September 26th, is the Science Center’s annual celebration convening the region’s leaders in support of cementing Philadelphia […]

Read More

For EDA Tech Hubs Designation, Philly’s Life Science Leaders Are Reaching Across State Lines

August 9, 2023

Ben Franklin Tech Partners is leading over 50 partners in applying for the federal program. Here’s why orgs from southeastern Pennsylvania, northern Delaware and southern New Jersey have all joined this consortium. Tech leaders from parts of Delaware, New Jersey and Pennsylvania are working together to apply for federal EDA Tech Hubs designation. The program run by […]

Read More

Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy

July 20, 2023

Advent Therapeutics, Inc., a biotechnology company pioneering an optimized retinol palmitate (vitamin A) drug product as a breakthrough non-invasive inhaled neonatal lung therapy, has been awarded a $3 million National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Phase IIB grant. This grant allows the Company to position its novel aerosolized vitamin A formulation […]

Read More

Cagent Vascular Announces Initial RECOIL Study Results: Serranator Demonstrates 49% Less Recoil Than POBA In BTK Arteries

July 19, 2023

Cagent Vascular, the exclusive developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its Below-the-Knee (BTK) RECOIL study. This Core Lab-Adjudicated Recoil analysis, the first of its kind, evaluated vessel recoil in lesions treated with Serranator® verses Plain Old Balloon Angioplasty (POBA). The study results demonstrated that lesions treated using […]

Read More

Previous Next